Form 4: Neogen Corp Executive Amy M. Rocklin Reports Acquisition of Shares and Stock Options
SEC Form 4
Amy M. Rocklin, Chief Legal Officer of Neogen Corp, reports the acquisition of common stock and stock options.
Summary
- Amy M. Rocklin, Chief Legal Officer of Neogen Corp, filed a Form 4 on August 19, 2024, reporting transactions made on August 15, 2024.
- Rocklin acquired 30,971 shares of common stock at a price of $16.79.
- Rocklin also acquired 145,718 stock options with an exercise price of $16.79, exercisable from August 15, 2024, and expiring on August 15, 2031.
- Following these transactions, Rocklin directly owns 72,335 shares of common stock and 355,613 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The acquisition of shares could be seen as slightly positive, but it's not a significant event.
Positives
- The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- Shareholders may view the executive's stock acquisition as a sign of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Date of earliest transaction: Acquisition of common stock and stock options. |
| 08/15/2024 | Date options become exercisable. |
| 08/15/2031 | Expiration date of the stock options. |
| 08/19/2024 | Date the Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.